A PYMNTS Company

U.S.: CVS subsidiary to pay over $5M for false drug pricing data allegations

By  |  October 16, 2012

CVS Caremark Corp, a unit of CVS stores, has agreed to pay $5.25 million to settle allegations against falsely reporting information of prescription drug prices between 2007 and 2008 to the government’s Medicare program. In January this year, CVS agreed to pay $5 million to resolve similar allegations filed by the Federal Trade Commission.

Full Content: Washington Post

Related Content: Healthcare Reform and Antitrust Enforcement: Provider Consolidation Encouraged, Scrutinized

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.